1. Home
  2. CSBR vs IDE Comparison

CSBR vs IDE Comparison

Compare CSBR & IDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

HOLD

Current Price

$7.33

Market Cap

90.0M

Sector

Health Care

ML Signal

HOLD

Logo Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

IDE

Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

HOLD

Current Price

$12.34

Market Cap

177.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSBR
IDE
Founded
1985
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
90.0M
177.6M
IPO Year
1986
N/A

Fundamental Metrics

Financial Performance
Metric
CSBR
IDE
Price
$7.33
$12.34
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
21.7K
33.5K
Earning Date
12-15-2025
01-01-0001
Dividend Yield
N/A
8.83%
EPS Growth
N/A
N/A
EPS
0.17
N/A
Revenue
$58,424,000.00
N/A
Revenue This Year
$7.31
N/A
Revenue Next Year
$12.01
N/A
P/E Ratio
$40.51
N/A
Revenue Growth
9.06
N/A
52 Week Low
$5.59
$8.61
52 Week High
$11.99
$10.46

Technical Indicators

Market Signals
Indicator
CSBR
IDE
Relative Strength Index (RSI) 54.60 68.26
Support Level $6.74 $12.05
Resistance Level $7.39 $12.10
Average True Range (ATR) 0.57 0.11
MACD 0.08 0.05
Stochastic Oscillator 44.50 97.92

Price Performance

Historical Comparison
CSBR
IDE

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

About IDE Voya Infrastructure Industrials and Materials Fund of Beneficial Interest

Voya Infrastructure, Industrials and Materials Fund is a diversified closed-end management investment company. The primary objective of this investment fund is to achieve total return by combining current income, capital gains, and capital appreciation. To achieve this objective, the fund invests in companies that own and/or operate infrastructure facilities in the infrastructure sector, as well as in a broad range of companies in the industrials and materials sectors that the Sub-Adviser believes will benefit from infrastructure building, renovation, expansion, and utilization.

Share on Social Networks: